Actionable news
0
All posts from Actionable news
Actionable news in CPIX: Cumberland Pharmaceuticals Inc.,

Schedule 13G/A

Filed by: ARIEL INVESTMENTS, LLC
Total Shares: 976,377
Subject Company: Cumberland Pharmaceuticals Inc - View Complete Ownership History Backtest
Filed as of Date: 07/10/2017
Event Date: 06/30/2017
Overall % Ownership: 6.1

Reporting Persons

Name Sole
Voting Power
Shared
Voting Power
Sole
Dispositive Power
Shared
Dispositive Power
Aggregate
Amount Owned
Percent
of class
Ariel Investments, LLC 597,350 0 976,377 0 976,377 6.1%

Raw Filing Contents

0000936753-17-000150.txt : 20170710
0000936753-17-000150.hdr.sgml : 20170710
20170710151543
ACCESSION NUMBER:		0000936753-17-000150
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20170710
DATE AS OF CHANGE:		20170710

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-85205
		FILM NUMBER:		17957682

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARIEL INVESTMENTS, LLC
		CENTRAL INDEX KEY:			0000936753
		IRS NUMBER:				020712418
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		200 EAST RANDOLPH STREET
		STREET 2:		SUITE 2900
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601
		BUSINESS PHONE:		(312) 726-0140

	MAIL ADDRESS:	
		STREET 1:		200 EAST RANDOLPH STREET
		STREET 2:		SUITE 2900
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARIEL CAPITAL MANAGEMENT LLC
		DATE OF NAME CHANGE:	20040218

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARIEL CAPITAL MANAGEMENT INC
		DATE OF NAME CHANGE:	19950202
SC 13G/A 1 cpix.txt SC13GA CPIX JUN17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.6)* Cumberland Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 230770109 (CUSIP Number) 06/30/2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) The remainder of this cover page shall be filled out for a reporting person's initial filing...

More